The primary aim of this study was to identify risk factors for developing neuritis and its impact on outcome following open reduction internal fixation (ORIF) of distal humerus fractures. Patients were identified from a prospective trauma database (1995–2010). All fractures of the distal humerus (OA-OTA Type A, B, C) managed with ORIF were included. Prospective long-term follow up was collected by telephone. Demographic data, fracture classification, intraoperative details (time to surgery, tourniquet, approach, fixation technique, nerve transposition), subsequent surgeries, presence of postoperative nerve palsy, complications and range of motion were collected. The Broberg and Morrey Elbow Score and DASH score were used as functional outcome measures. Eighty-two patients, mean age 50(range, 13–93) were included. 16% (13/82) developed post-operative ulnar neuritis, 7% (6/82) radial neuritis and 5% (4/82) longterm nonspecific dysaesthesia. Short-term (mean 10 months, range 1–120, collected in 82 patients) and long-term (mean 6 years, range 4–18, collected in 45%, 34/75, of living patients) was completed. In patients with nerve complication: average Broberg and Morrey score was 86 (76% good/excellent), average DASH was 24.7(range, 3.3–100) and Oxford Elbow Score was 39.5(range, 18–48). Compared to: 94 (96% good/excellent), 17.7(range, 0–73.3) and 43.8(range, 17–48) in patients without. Mean pain score was 3.7 in patients with nerve complication compared to 2 without. Nerve complications were seen with increased frequency in young, male patients with high energy and Type C injuries. Nerve complication following ORIF of distal humerus fractures is relatively common. They have detrimental impact on functional outcome. Certain groups appear to be at increased risk

Introduction. Adequate exposure is a prerequisite for treatment of distal humeral fractures. In this study, we compared the clinico-radiological and functional outcome of TRAP approach with that of olecranon osteotomy for distal humerus fractures. Material & Methods. 27 patients with distal humerus fractures were randomized into 2 groups: Group 1 (n=14, TRAP approach), Group 2 (n=13, Olecranon osteotomy). All patients were operated with bi-columnar fixation. All patients were mobilized from day 2. Follow-up evaluation was done at 1, 3, 6 and 12 months. Results. All patients achieved union. The mean surgical time was higher in group 1 (120 min) as compared to group 2 (100 min). The final ROM was higher in group 1 (1160) as compared to group 2 (850). Two patients in group 2 needed posterior release. 5 patients in group 2 had hardware complications related to olecranon osteotomy and needed removal. Two patients in Group 1 had transient ulnar nerve paraesthesias. There was no difference in triceps power in both groups. Conclusion. Our results demonstrate that TRAP approach is extensile and safe enough in treating these complex fractures with better final ROM and fewer complications

An increasing number of distal humeral fractures are presenting as fragility fractures in low demand elderly patients. The optimal management of these injuries remains controversial. The primary aim of this study was to document the short and long term outcomes of these fractures treated with primary nonsurgical intervention. All patients were identified from a prospective trauma database from 1995 to 2010. All conservatively managed, isolated fractures of the distal humerus (OTA Type A,B,C) were included. Prospective long term follow up was collected by telephone interview. Demographic data, fracture classification, management protocol, subsequent surgeries, complications, range of motion, function and patient reported outcomes were recorded. The primary short-term outcome measure was the Broberg and Morrey Elbow Score. The primary long-term outcome measure was the DASH score. Sixty-two patients were included. Mean age 76 (range, 11–96). Low-energy injuries were seen in 97% (59/61) of patients and ≥1 co-morbidities in 50% (27/54). At a mean of 3.7 months (range, 1–14) mean Broberg and Morrey score was 86 (range, 52–100); 70% (28/40) achieving excellent or good short-term outcome. Long-term follow-up was available in 17% (n=11) patients, with 75% (48/64) deceased. At a mean of 7 years (range, 4–17) mean DASH was 23.6 (range, 0.8–45.8), mean Oxford Elbow Score was 42 (range, 32–48). Overall patient satisfaction was 100% (n=11). One patient subsequently underwent open reduction internal fixation for malunion. We have reported satisfactory short-term and longer-term outcomes following the nonsurgical management of isolated distal humerus fractures in older lower demand patients

Aims

Heterotopic ossification (HO) is a common complication after elbow trauma and can cause severe upper limb disability. Although multiple prognostic factors have been reported to be associated with the development of post-traumatic HO, no model has yet been able to combine these predictors more succinctly to convey prognostic information and medical measures to patients. Therefore, this study aimed to identify prognostic factors leading to the formation of HO after surgery for elbow trauma, and to establish and validate a nomogram to predict the probability of HO formation in such particular injuries.

Background. For the treatment of proximal humeral fractures two major therapeutic principles can be employed: Intramedullary nailing (PHN) or locking plate osteosynthesis. Aim of this study was to evaluate and compare clinical and radiological long-term outcome of proximal humeral fracture stabilization using PHN or angular stable plating. In addition, we discussed advantages and disadvantages of both techniques and aimed at establishing criteria which operative technique should preferentially be utilized for selected fracture configurations. Materials and Methods. In a prospective study between 2003 and 2010 we analyzed 72 patients with proximal humeral fracture who had been treated by PHN (44 patients) or angular stable plating (28 patients) in a European Level 1 Trauma Center. In the two cohort groups the following epidemiologic data was found. 46 patients were women, and 26 men with a mean age of 60.6 years (range 18–91). Follow-up was performed 38–82 months after accident, on average. Mechanism of injury was fall in 59, motor cycle accident in 4, bike accident in 8 patients, and fall from horse in 1 patient. Duration time between accident and operation was 2.8 days on average. Osteoporosis was previously known in 20 out of all evaluated patients (plate: 7/28; nail: 13/44). Fractures were classified using the Neer classification and Binary description system: There were 35 3-part fractures (PHN: 26; plate: 9) and 37 4-part fractures (PHN: 18; plate: 19), respectively. Functional and radiological outcome was assessed in a range of 38–82 months after trauma using Constant Score. Results. No clinical symptoms after 3 years were observed in 40 patients, whereas in 32 patients clinical symptoms were evaluated related to pain and/or loss of function. Secondary revision after plate fixation had to be performed in 5 out of 28 patients and in 11 out of 44 patients in the PHN group. Functional outcome using the Constant score demonstrated a total score of 72.9 (ipsi-lateral side) vs. 88.4 (contra-lateral side) in all evaluated patients, on average. Complete metal removal was performed in 34 out of 72 patients (PHN: 17; plate: 17). Conclusion. Both i.m. nailing and angular stable plating are adequate treatment options for proximal humeral fractures. No significant differences in outcome between implants regarding fracture healing, nonunion, and infection were found. Locked plating can be utilized for all distal humerus fracture including complex 4-part fractures. I.m. nailing provides favorable intramedullary stability and can be successfully implanted in multi-segmental fractures of the upper extremity. However, both systems require precise preoperative planning and advanced surgical experience. Clinical long-term outcome largely depends on surgical technique and not so much on the choice of implant

We reviewed 59 bone graft substitutes marketed by 17 companies currently available for implantation in the United Kingdom, with the aim of assessing the peer-reviewed literature to facilitate informed decision-making regarding their use in clinical practice. After critical analysis of the literature, only 22 products (37%) had any clinical data. Norian SRS (Synthes), Vitoss (Orthovita), Cortoss (Orthovita) and Alpha-BSM (Etex) had Level I evidence. We question the need for so many different products, especially with limited published clinical evidence for their efficacy, and conclude that there is a considerable need for further prospective randomised trials to facilitate informed decision-making with regard to the use of current and future bone graft substitutes in clinical practice.

Cite this article: Bone Joint J 2013;95-B:583–97.